The Growth Characteristics and Response to Hormones of Transplanted Fibrosarcoma Arising from Mammary Fibroadenoma in the Rat by Millar, M. Jean & Noble, R. L.
508
THE GROWTH CHARACTERISTICS AND RESPONSE TO HOR-
MONES OF TRANSPLANTED FIBROSARCOMA ARISING FROM
MA1MARY FIBROADENOMA IN THE RAT.
M. JEAN MILLAR AND R. L. NOBLE
From the eollip Medical Research Laboratory, Universityof Western Ontario,
London, Canada.
Received for publication July 6, 1954.
THE growth characteristics and morphology of transplanted mammary
fibroadenomata and the effect ofendogenous and exogenous hormones upon thenm
have been presented in the two preceding papers (Millar and Noble, 1954a and
1954b). A transformation to fibrosarcoma occurred fairly frequently in such
benign tumours and in many cases it was possible to detect fibrosarcomatous.
tissue within a fibroadenoma by macroscopic examination alone. By trans-
planting this tumour tissue many sub-lines offibrosarcomata have been developed
from the single line of fibroadenomata studied. The growth characteristics and
pathology of these sub-lines are described briefly herein and compared with the
fibroadenomata from which they originated.
There is considerable evidence in the literature to indicate that the fibrosarco-
matous transformation constitutes a permanent modification of the growth
characteristics of the original fibroadenoma. Increased takes (Heiman, 1934;
Selbie, 1941) and growth-rate (Emge, 1938) have been noted when transplanted
fibrosarcomata offibroadenomatous origin were compared with the fibroadenoma.
These tumours are reported to growequally well in male andfemale rats (Oberling,
Guerin and Guerin, 1935; Selbie, 1941) and in rats of different strains (Heiman
1934), characteristics not common to fibroadenomata. Heiman (1934) also found
that the amount of X-radiation required to kill fibrosarcoma and fibroadenoma
cells was 3500 r and 5500 r respectively. In order to produce further evidence of
this alteration in response to environmental conditions, experiments were under-
taken to determine the effect on transplanted fibrosarcomata ofhormonal prepar-
ations known to influence the growth of the benign fibroadenoma. These were




Fibrosarcoma lines developed from fibroadenoma were identified by the letters
FM.-: a number before these letters distinguishing the individual lines and a
number following, the transplant generation. At least one tumour of each trans-
plant generation was examined microscopically.
Young adult female rats of the Sprague-Dawley strain were used in these
studies. Details of transplantation technique (using single axillary implants)
and the method for assessing the effects of different treatments within transplantGROWTH CHARACTERISTICS OF TRANSPLANTED FIBROSARCOMA
series is given in the first of the two preceding papers (Millar and Noble, 1954a).
For convenience a brief review of the latter is given below. After growth initia-
tion, the tumours were measured once or twice weekly (depending on the growth-
rate) till the death of the animal. Tumour size (in square inches) was plotted
against time and from such growth curves figures were obtained for "latent"
and "growth" periods. These were defined respectively as the time from the
implantation date till the tumour was 0.4 square inches in area and the time for
the tumourtogrowfrom 0 4to 3 0 squareinches. Meantumourlatent andgrowth
periods for treated and control groups were compared by the " t " test ofFisher,
usingaprobability of 0 05 as the level ofsignificance. All meanswillbepresented
with their standard errors.
Three separate experiments using different FM tumour lines were conducted to
determine the effect of estrogen at high dose levels and a beef anterior pituitary
suspension on the growth of the fibrosarcomata. Diethylstilbestrol was given
orally as a constituent ofthe drinking water (0 5 mg. per cent) or by subcutaneous
injection in sesame oil solution. Dose levels were approximately 50 ,ug. daily by
the former and 200 ,ug. every second day by the latter mode of administration.
As an added control in one experiment, a group of rats was subjected to dietary
restriction sufficient to produce weight loss comparable to that observed in the
estrogen injected rats. Preparation of the beef anterior pituitary saline suspen-
sion is outlined in a previous paper (Millar and Noble, 1954b). It was adminis-
tered every second day by subcutaneous injection in an amount equivalent to
200 mg. of anterior pituitary substance (1 ml.). All treatment began at the time




The first paper ofthis series (Millar and Noble, 1954a) gave a detailed descrip-
tion of the macroscopic and microscopic pictures of fibroadenomata which have
undergone a fibrosarcomatous transformation. Variation in the degree of
cellularily, anaplasia and mitotic activity led to the classification ofthis tissue as
suspicious-low, low, moderate and high grade fibrosarcoma. Bony and cartila-
genous metaplasia was observed in some tumours and has become quite character-
istic of one FM tumour line after the second generation. Photomicrographs of a
high grade fibrosarcoma and the metaplastic change were shown in the earlier
paper (Millar and Noble, 1954a, Fig. 6 and Fig. 7).
Forty-two fibroadenomata suspected of having undergone a change to fibro-
sarcoma were transplanted. Of these, six grew as unchanged fibroadenomata,
two were identified as fibroma, while the remainder fell into the above grades of
fibrosarcomata. Although the bulk of the FM lines were classified initially as
suspicious low-grade or low-grade fibrosarcomata, these tumours tended to change
to the more cellular, anaplastic forms in the course of transplantation. In only
one instance was there a reversion to a lower grade (37 FM to 37 FMl-moderate
to low-grade fibrosarcoma).
(2) Growth characteristics ofFM tumour lines.
The growth energy of FM tumour lines varied considerably. The percentage
takes ranged between zero and 100; the majority being 50 to 75 per cent in small
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groups of four or five rats. Latent periods for first generation tumours ranged
from 7 to 61 days. Growth was usually fairly rapid, but as the tumours were
measured only when experiments such as those to be reported were being coln-
ducted, quantitative data is not complete for this aspect. The mean "growth
periods" given in Table I are representative of most of the tumours observed,
although considerably slower growth than these figures indicate was not uncom-
mon. Metastases have not been observed.
Correlation between the pathological grade of fibrosarcoma and the growth
characteristics was by no means clear cut. With reference to the latent periods
given above, only the lines originating from high-grade fibrosarcomata gave any
indication of being a distinct group. The range for these tumours was 8 to 20
days, while the lower grades varied within the limits given, i.e., 7 to 61 days. In
general it can be said only that the chances of obtaining rapidly growing, easily
transplantable tumours, from tissue classified as moderate or high-grade fibro-
sarcoma exceed those from the two lower grades.
The pathological change from fibroadenoma to fibrosarcoma was accompanied
by alterations in growth characteristics ofthe tumour and the response ofthe host
to the tumour mass. Although there was considerable overlap in the range of
latent and growth periods for fibroadenomata and fibrosarcomata, as a group of
the FM tumours were more readily propagated and faster growing. The effect of
the fibrosarcomata on the general health of the host varied considerably for
individual tumours. Slow growing tumours were usually well tolerated, while
the more rapidly growing ones were more deleterious to the health ofthe tumour-
bearer. However, in no instance has an FM tumour reached a size ofover 150 g.
(5.0 to 7-0 square inches) without causing weight loss and cachexia. Death has
occurred in some animals before the tumour has reached 3.0 square inches in size
and could be attributed to no other obvious pathology. The depletion during
the growth period ofseveral groups may be noted in Table I. On the other hand,
fibroadenomata of size equal to or exceeding the body-weight of the host do not
appear to harm the tumour-bearer except through the physical disability resulting
from the enormous tumour mnass.
(3) The effect of estrogen at high dose levels and an anterior pituitary preparation
on the growth ofFM tumours.
The tumour lines used in these experiments were as follows:
15 FM2-: high-grade fibrosarcoma
35 FM5- : moderate-grade fibrosarcoma (35 FM4-: low-grade fibro-
sarcoma)
42 FM2- : high-grade fibrosarcoma.
The results for theexperimental groups ofeach tumour line are given in Table I.
The mean latent period and the mean growth period of 15 FM and 35 FM lines
respectively were significantly longer in diethylstilbestrol treated rats. A similar
trend was noted in the 42 FM line, but the differences were not significant. Diet-
ary restriction caused no retardation in tumour-growth in this experiment. The
anterior pituitary suspension did not alter the growth trend of any of the three
tumour lines studied.
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TABLE I.-The Effect of Estrogen at High Dose Levels and an Anterior Pituitary
Suspe?mion on the Growth of FM Turnours.
Mean
latent Mean growth
Tumour No. of No. of period period
line. Treatment. rats. takes. (days). (days).
15 FM Diethylstilbestrol* . 8 . 8 . 13±1411 22±3- 1 (5 rats)
Anterior pituitary suspension 8 . 8 9+0 3 . 18±i2-5
Controls . . 8 . 5 . 9±0 4 18 1 9
35 FM .Diethylstilbestrolt . . 8 8 . 26±1-0 . 22i1 511 (6 rats)
Anterior pituitary suspension . 8 . 6 . 25±0-6 13+1.3 (4 rats)
Controls . . . 8 . 6 27±i1-4 . 15±1.6 (5 rats)
42 FM . Diethylstilbestrolt . 8 . 8 . 17±1-1 . 23±1-6 (7 rats)
Anterior pituitary suspension . 8 . 8 15 i 1-5 . 18± l- 1
Dietary restrictiont . . 8 . 8 . 13i0-4 . 19±1.9
Controls . . . 8 8 . 14±1-4 . 21±1-8 (7 rats)
* Diethylstilbestrol given orally in drinking water-approximately 50 ,g. daily.
t Diethylstilbestrol injected subcutaneously-200 ,ug. every second day.
. Dietary restriction-sufficient to produce weight loss, comparable to that observed in diethyl-
stilbestrol injected rats.
IP < 0.05-Treated versus controls.
DISCUSSION.
The results presented are in accordance with those reported by others. The
sub-lines of fibrosarcomata arising from a single fibroadenoma line produced in
general more rapidly growing, independent tumours than the fibroadenomata.
Thebodyweight loss andearly death offibrosarcoma-bearing rats was not observed
for rats bearing fibroadenomata of similar or much larger size. Similarly, Emge
(1938) reported that such fibrosarcomata caused the death of the host in 30 to 40
days. Metabolic differences have also been noted. Begg, Dickinson and Millar
(1953) observed that the reduction in liver catalase activity was significantly
greater in rats bearing transplanted fibrosarcomata or fibroadenomata of which a
portion had become sarcomatous than in rats bearing totally benign fibroadeno-
mata.
The histological appearance and the growth properties point to the classifica-
tion of these tumours as malignant growths. Metastases have not been observed
in FM tumour-bearing rats, but Emge (1938) noted that these fibrosarcomata
recurred rapidly after surgical removal, while Heiman (1934) observed local inva-
sion into the chest wall of one such tumour. Increased autonomy as shown by
diminished or negative response to hormonal factors known to influence the
fibroadenoma offers further evidence of the true malignancy of these growths.
Diethylstilbestrol administered at similar dose levels prevented the initiation of
growth in fibroadenoma implants, or arrested or markedly slowed the growth of
growing tumours (Millar and Noble 1954b). The comparatively slight, but
usually significant growth retardation shown by FM tumnours was similar to that
observed with estrogen administration for other malignant growths, including
sarcomata (Nathanson and Salter, 1939; Eisen, 1941). Fibroadenoma-stimu-
lating hormones present in beef anterior pituitaries did not enhance the growth of
FM tumours. This confirms the alternate findings of Emge and Murphy (1936)
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that growth of similar tumours in hypophysectomised rats was only slightly
depressed, if at all.
The existence and propagation of benign and malignant growths of common
origin offers a tool for cancer research which may be of considerable value. The
use of the benign tumour-bearer as a more representative control for the study
of malignant tumour-host relationships has already been reported for liver-
catalase studies by Begg, Dickinson and Millar (1953). It is possible too that the
more gradual development of malignancy from normal tissue through the benign
neoplasm, would reveal in metabolic studies more subtle changes than can be
detected in comparing only normal and malignant tissue of common origin.
SUMMARY.
1. The pathology and growth characteristics of tumour lines originating from
fibrosarcomatous tissue occurring in transplanted mammary fibroadenomata are
described.
2. In comparing these tumours with the benign growths oftheir origin, it was
noted that the fibrosarcomata were usually faster growing and more easily pro-
pagated than the fibroadenomata. In addition they exerted a deleterious effect
upon the health of the host, causing weight loss and death. No comparable
response was observed in rats bearing fibroadenomata.
3. Diethylstilbestrol at high dose levels caused slight but usually significant
retardation oftumour growth, a response similar but not comparable in degree to
that observed with the fibroadenoma.
4. A crude beef anterior pituitary suspension known to enhance the growth of
fibroadenomata did not alter the growth energy of fibrosarcomata.
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